Target intelligence / Profile preview

RNA polymerase II subunit L pseudogene 1 (POLR2LP1)

Target
POLR2LP1
Molecular classification
Other (Pseudogene)
01

Overview

RNA polymerase II subunit L pseudogene 1 (POLR2LP1) is classified as a pseudogene in the human genome. Pseudogenes resemble functional genes but have lost their protein-coding ability or are otherwise non-functional due to mutations or lack of necessary regulatory elements. In this case, POLR2LP1 relates to the gene POLR2L, which encodes a small subunit (subunit L) of RNA polymerase II, a complex essential for transcription in eukaryotes. However, POLR2LP1 itself does not encode a functional product and has no known biological activity or role in disease[4][6]. It is not considered a therapeutic target, is not druggable, and is not associated with any disease phenotype or pharmacological mechanism. There is no evidence of its use as a biomarker or its involvement in patient safety or efficacy monitoring. Key points: - POLR2LP1 is a **pseudogene** and not a functional protein-coding gene[4][6]. - POLR2LP1 is not a recognized therapeutic target. - It does not participate in any known biological function or disease process. - No drugs or mechanisms of action are associated with this gene. - No role as a biomarker or source of safety concern. If you are seeking information about the functional RNA polymerase II subunit L, the gene to reference is **POLR2L** (RNA polymerase II, I and III subunit L), not POLR2LP1[8].

Other names
AB023060.6POLR2LPpolymerase (RNA) II (DNA directed) polypeptide L pseudogenepolymerase (RNA) II subunit L pseudogene 1

Beyond the preview

Go deeper on RNA polymerase II subunit L pseudogene 1 (POLR2LP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase II subunit L pseudogene 1 (POLR2LP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call